Literature DB >> 7507134

Cellular adhesion antigen modulation in purpura pigmentosa chronica.

P von den Driesch1, M Simon.   

Abstract

BACKGROUND: Purpura pigmentosa chronica is an inflammatory skin disorder probably caused by an allergic reaction. Delayed-type hypersensitivity or immunocomplex vasculitis has been considered as a possible mechanism.
OBJECTIVE: Detailed analysis of cell adhesion molecule (CAM) modulation may give further insights into the pathogenesis and underlying immune reaction of this disease.
METHODS: By immunohistochemical techniques we investigated the in situ expression of integrins, selectins, and CAMs of the immunoglobulin superfamily.
RESULTS: Infiltrating lymphocytes expressed LFA-1, LFA-2, VLA-4, and VLA-5, whereas some of the macrophages were also positive for p150/95 and MAC-1. VLA-1 was found on lymphocytes near the basement membrane of the epidermis. Compared with uninvolved or healthy skin endothelial cells showed upregulation of ICAM-1, VCAM-1, and, focally, E-selectin. Some fibroblasts were positive for ICAM-1. ICAM-1 was also upregulated on lesional keratinocytes that also expressed alpha 2, alpha 3, and alpha 6 integrin chains on basal and suprabasal epidermal layers.
CONCLUSION: Our findings demonstrate characteristic modifications in the expression of CAMs in purpura pigmentosa chronica and indicate the involvement of the epidermis in this disease. This modulation shows close parallels to those described for chronic delayed-type immune reactions of the skin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7507134     DOI: 10.1016/s0190-9622(94)70016-8

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  3 in total

1.  Expression of integrin receptors and ICAM-1 on keratinocytes in vivo and in an in vitro reconstructed epidermis: effect of sodium dodecyl sulphate.

Authors:  P von den Driesch; M Fartasch; A Hüner; M Ponec
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

2.  [Bufexamac-induced pigmented purpuric eruption].

Authors:  K Waltermann; W Ch Marsch; B Kreft
Journal:  Hautarzt       Date:  2009-05       Impact factor: 0.751

3.  TNF-α inhibitor induced pigmented purpuric dermatoses: a case report.

Authors:  Divita Jhaveri; Frances Zhao
Journal:  BMC Rheumatol       Date:  2022-04-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.